Viela Bio Inc (VIE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -150,668 | -86,429 | -190,270 |
| Depreciation Amortization | 3,094 | 174 | 18 |
| Accounts receivable | 24,615 | -30,000 | N/A |
| Other Working Capital | 29,233 | -22,419 | 15,509 |
| Other Operating Activity | -12,387 | 33,625 | 145,212 |
| Operating Cash Flow | $-106,113 | $-105,049 | $-29,531 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -404,135 | -161,036 | N/A |
| PPE Investments | -926 | -1,101 | -491 |
| Sale Of Investment | 300,511 | 15,691 | 0 |
| Purchase Sale Intangibles | -19,700 | N/A | N/A |
| Other Investing Activity | -19,700 | 0 | -143,333 |
| Investing Cash Flow | $-124,250 | $-146,446 | $-143,824 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -106 | N/A | N/A |
| Common Stock Issued | 170,545 | 158,448 | 0 |
| Other Financing Activity | -10,862 | 167,000 | 300,253 |
| Financing Cash Flow | $159,577 | $325,448 | $300,253 |
| Beginning Cash Position | 200,851 | 126,898 | N/A |
| End Cash Position | 130,065 | 200,851 | 126,898 |
| Net Cash Flow | $-70,786 | $73,953 | $126,898 |
| Free Cash Flow | |||
| Operating Cash Flow | -106,113 | -105,049 | -29,531 |
| Capital Expenditure | -926 | -1,101 | -491 |
| Free Cash Flow | -107,039 | -106,150 | -30,022 |